Albireo is studying new approaches for modulating acids with new compounds to address adult liver disease. Adult cholestatic diseases are a diverse group of disorders known for the appearance of jaundice, fatigue, pruritus and/or complications of cirrhosis. The most common adult cholestatic liver diseases are primary biliary cholangitis and primary sclerosing cholangitis, with approximately 600,000 adults diagnosed globally. About 11 million adults suffer from viral liver diseases globally.
To learn more about liver disease, visit the American Liver Foundation.
This is not an exhaustive list of organizations. Albireo assumes no responsibility for information or statements on external websites.